✦ LIBER ✦

Drug-induced dystonia and dysphonia in Parkinson's disease

✍ Scribed by Kiyoshi Negoro; Mitsunori Morimatsu; Hiroshi Nogaki

Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 32 KB
Volume: 14
Category: Article
ISSN: 0885-3185
DOI: 10.1002/1531-8257(199903)14:2<386::aid-mds1040>3.0.co;2-w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Severe off-period facial dystonia in Par

Severe off-period facial dystonia in Parkinson's disease

✍ Marcelo Miranda; Pedro Chaná 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 1 views

Quetiapine for the treatment of drug-ind

Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease

✍ Hubert H. Fernandez; Joseph H. Friedman; Carol Jacques; Michael Rosenfeld 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 25 KB 👁 2 views

Atypical antipsychotics in the treatment

Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease

✍ Joseph H. Friedman; Stewart A. Factor 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

Clozapine replacement by quetiapine for

Clozapine replacement by quetiapine for the treatment of drug-induced psychosis in Parkinson's disease

✍ Hubert H. Fernandez; Margaret C. Lannon; Joseph H. Friedman; Bruce P. Abbott 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 2 views

Cases of delayed or acute posttraumatic, therapy-resistant tremor have been previously described. [1][2][3][4] The onset is usually delayed (weeks to months/years), but they may also begin rapidly (within hours). Careful neuroradiologic examination may reveal small lesions, often in the deep brain a

Selegiline and mortality in Parkinson's

Selegiline and mortality in Parkinson's disease

✍ Dr. C. W. Olanow; S. Fahn; J. W. Langston; J. Godbold 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 489 KB 👁 2 views

## Do Other Studies Show Increased Mortality Due to Selegiline? Other than the UK study, no clinical trial to date has shown an increase in mortality in association with the use of selegiline. In the Sindepar study, a cohort of I01 untreated P D patients participated in a 14-month prospective, ran

Accelerometric assessment of levodopa-in

Accelerometric assessment of levodopa-induced dyskinesias in Parkinson's disease

✍ J.I. Hoff; A.A. v/d Plas; E.A.H. Wagemans; J.J. van Hilten 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views

Our objective was to develop parameters for objective ambulatory measurements of levodopa-induced dyskinesias (LID) in patients with Parkinson's disease (PD). Twentythree PD patients with mild to severe LID were submitted to a standardized protocol of 1-minute recordings during rest, talking, stress